Ongoing research increasingly shows that autologous serum and plasma-derived therapies are generally useful in the treatment of ocular surface disorders such as dry eye syndrome and persistent ...
Recently-developed assays target tau phosphorylated at threonine 217 (tau-p217). In a meta-analysis of two studies, levels of plasma tau-p217 showed a non-significant trend towards elevation in ...
Recently developed assays target tau phosphorylated at threonine 217 (tau-p217). Both eligible studies found greater levels of plasma tau-p217 in people with Alzheimer’s disease than controls, albeit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results